
Bortezomib 2 mg (Bortecad) is a prescription anticancer medicine used to treat certain blood cancers, particularly multiple myeloma and mantle cell lymphoma. It belongs to a class of medicines called proteasome inhibitors, which interfere with the protein-processing system inside cancer cells. This action helps prevent cancer cells from growing and multiplying.
| Generic Name | Bortezomib |
| Manufacturer | Cadila Pharmaceuticals Ltd |
| Packing | 1 vial |
| Prescribed For | Multiple myeloma and mantle cell lymphoma |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Bortezomib works by blocking proteasomes, which are protein-processing structures inside cells. Cancer cells depend on these structures to remove unwanted or damaged proteins. When proteasome activity is inhibited, abnormal proteins accumulate inside cancer cells, triggering cellular stress and eventually causing cell death. This helps control the growth and multiplication of cancer cells.